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Background: Isolated premature ventricular complexes (PVCs) are often benign, but occasionally frequent idiopathic PVCs have been observed in 
patients with dilated cardiomyopathy. Case reports have demonstrated improvement in cardiac function following successful radiofrequency ablation 
(RFA) for frequent PVCs. We sought to evaluate our single center experience.
Methods: We reviewed consecutive patients with idiopathic, frequent, isolated PVCs and impaired left ventricular ejection fraction (LVEF) <50%, 
who underwent focal RFA from 1997-2009. Patients with coronary artery disease, valvular heart disease, sustained ventricular tachycardia (VT), and 
non-sustained VT >1% of total beats were excluded. We then identified consecutive subjects who underwent Holter monitoring with similar selection 
criteria and significant PVCs (>10% beats/hour) but no RFA as control.
Results: In our study cohort of 23 subjects (mean age 43 ±32 years, 61% male, mean LVEF 33±18%, mean left ventricular (LV) end diastolic 
dimension 5.5±1.2cm, mean PVC burden 840 beats/hour), we observed PVCs originated from right ventricular outflow tract in 16 subjects (70%), 
LV outflow tract in 6 subjects (26%), and mitral annulus in 1 subject (4%). Following RFA, mean LVEF improved for 20 out of 23 subjects (87%) 
from 32±19% to 47±17% (p<0.001). This directly corresponded to reduction of PVC burden from 816/hr to 40/hr (p<0.001). In particular, LVEF 
normalized (≥50%) in 12 of these 20 patients. In the control group of 9 patients receiving only antiarrhythmic therapy (including beta blockers), 
LVEF increased from 27±23% to 35±25% (p=0.11), with PVC burden decreasing from 346/hr to 167/hr (p=0.22).
Conclusions: Identifying frequent PVCs in the setting of dilated cardiomyopathy may provide an important therapeutic target via RFA to reduce PVC 
burden and improve LVEF.
